Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1440 participants.
Also called NCT06010628
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,440 participants
- Registry
-
NCT06010628
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06010628. Randomized; single masking; primary purpose treatment. Start 2024-02-01 (actual); primary completion 2029-12-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)
- Condition
- Stroke, Ischemic
- Intervention (Drug)
- Tenecteplase
- Lead sponsor
- General Hospital of Shenyang Military Region
Record details
- Record id
cardio:ct-nct06010628- Content hash
127a181010bdd25ec61a1ad805b7c978327b91150998b6f870aa8ac2ccfb6c8c